FibroGen, Inc.
Nitrogen-containing heteroaryl compounds and methods of use thereof

Last updated:

Abstract:

The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Status:
Grant
Type:

Utility

Filling date:

22 Aug 2018

Issue date:

12 May 2020